ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 587,14
-0,60%
Dow Jones
40 211,72
0,53%
DAX
18 517,02
-0,45%
Brent Oil
83,66
-0,81%
Bitcoin
63 224,87
-2,51%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
01/03/202322h13Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NYSE:TEVATeva Pharmaceutical Industries Ltd
01/03/202322h11Business WireTeva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent) Sustainability-Linked Senior Notes and the Increase of the Maximum Tender Amount of its Debt Tender OfferNYSE:TEVATeva Pharmaceutical Industries Ltd
27/02/202309h30Business WireTeva Announces Launch of $2,060,000,000 (Equivalent) Offering of Sustainability-Linked Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
27/02/202309h30Business WireTeva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026NYSE:TEVATeva Pharmaceutical Industries Ltd
24/02/202314h00Business WireTeva to Present New Data from CONNECT2 Study on its Digihaler® System at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
23/02/202314h00Business WireTeva Announces Publication of New Clinician Scale in Journal of Clinical Psychiatry to Assess the Impact of Tardive Dyskinesia on Patients’ LivesNYSE:TEVATeva Pharmaceutical Industries Ltd
18/02/202300h03Dow Jones NewsTeva Gets FDA Approval for Movement Disorders TreatmentNYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/202322h56Business WireTeva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) TabletsNYSE:TEVATeva Pharmaceutical Industries Ltd
15/02/202313h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
13/02/202321h33Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/202313h04Edgar (US Regulatory)Annual Report (10-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
09/02/202315h05Dow Jones NewsTeva to Pay Florida $6.7 Million to Settle Price-Fixing AllegationsNYSE:TEVATeva Pharmaceutical Industries Ltd
09/02/202314h00Business WireTeva Reaches Agreement With Florida to Settle the State’s Price Fixing ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
08/02/202322h23Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)NYSE:TEVATeva Pharmaceutical Industries Ltd
08/02/202313h00Business WireTeva Reports Fourth Quarter and Full Year 2022 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
23/01/202315h35Dow Jones NewsTeva Seeks FDA OK for Generic Form of Catalyst's FirdapseNYSE:TEVATeva Pharmaceutical Industries Ltd
19/01/202313h00Business WireTeva’s Ambitious Climate Targets Externally Validated by the Science Based Targets initiative (SBTi)NYSE:TEVATeva Pharmaceutical Industries Ltd
12/01/202322h30Business WireTeva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023NYSE:TEVATeva Pharmaceutical Industries Ltd
09/01/202315h13Dow Jones NewsTeva Moves Forward With Nationwide Opioid SettlementNYSE:TEVATeva Pharmaceutical Industries Ltd
09/01/202314h00Business WireTeva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
06/01/202320h21Dow Jones NewsAlvotech, Teva Shares Rise After FDA Accepts BLA for AVT04NYSE:TEVATeva Pharmaceutical Industries Ltd
06/01/202313h00Business WireAlvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
03/01/202322h30Business WireTeva to Present at the 41st Annual J.P. Morgan Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
22/12/202210h00GlobeNewswire Inc.Update on U.S. Regulatory Status of AVT02, Alvotech’s Proposed High-Concentration, Interchangeable Biosimilar to Humira®NYSE:TEVATeva Pharmaceutical Industries Ltd
13/12/202219h24Dow Jones NewsVanda Pharmaceuticals Shares Tumble After Loss in Hetlioz Patent SuitNYSE:TEVATeva Pharmaceutical Industries Ltd
23/11/202208h44Dow Jones NewsTeva, Allergan Finalize Terms of Nationwide Opioid Settlement -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
22/11/202214h30Business WireTeva Finalizes Nationwide Opioid Settlement TermsNYSE:TEVATeva Pharmaceutical Industries Ltd
21/11/202213h02Edgar (US Regulatory)Current Report Filing (8-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
21/11/202213h00Business WireTeva Announces Appointment of Richard Francis as President and CEONYSE:TEVATeva Pharmaceutical Industries Ltd
14/11/202214h01Business WireTeva Announces Unique Collaboration with Rimidi to Expand the Reach of its Respiratory Digital Health PlatformNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
AI
Air Liquide
NASDAQ
AAPL
Apple
EU
PX1
CAC 40
EU
VIV
Vivendi
EU
BNP
BNP Paribas
NASDAQ
GOOGL
Alphabet
FTSE
UKX
FTSE 100
COIN
BTCUSD
Bitcoin
NYSE
NKE
Nike
EU
HO
Thales
EU
AF
Air FranceKLM
EU
PX4
SBF 120
EU
EN
Bouygues
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés